Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate Cancer.

bioRxiv : the preprint server for biology·2026
Same author

Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.

Molecular oncology·2026
Same author

Occupation as a firefighter and cancer mortality in a population-based cohort in the United States.

International journal of epidemiology·2025
Same author

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial.

European urology oncology·2025
Same author

Stereotactic implantation of diffusing alpha-emitters radiation therapy sources in the swine brain: a potential new focal therapy for brain tumors.

Journal of neuro-oncology·2025

Related Experiment Video

Updated: May 4, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.3K

AR function in promoting metastatic prostate cancer.

Michael A Augello1, Robert B Den, Karen E Knudsen

  • 1Department of Cancer Biology, Thomas Jefferson University, 233 10th St., BLSB 1008, Philadelphia, PA, 19107, USA, Michael.augello@jefferson.edu.

Cancer Metastasis Reviews
|January 16, 2014
PubMed
Summary
This summary is machine-generated.

Prostate cancer progression to metastatic stages is driven by androgen receptor (AR) signaling. Understanding AR-specific pathways is crucial for developing effective treatments for advanced prostate cancer (PCa).

More Related Videos

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.1K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K

Related Experiment Videos

Last Updated: May 4, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.3K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.1K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Prostate cancer (PCa) is a major cause of cancer mortality in the USA.
  • Localized PCa is treatable, but metastatic disease requires targeting the androgen receptor (AR) signaling axis.
  • Tumors eventually develop resistance, leading to castration-resistant prostate cancer (CRPC) and PCa-specific death.

Purpose of the Study:

  • To review the functional significance of AR signaling pathways in prostate cancer metastasis.
  • To define the molecular underpinnings of AR-driven metastatic signatures.
  • To highlight AR's role in both early and late-stage metastatic disease.

Main Methods:

  • Review of clinical and preclinical evidence implicating AR signaling in metastasis.
  • Identification of downstream AR targets and cofactors involved in metastatic phenotypes.
  • Analysis of AR-specific programs facilitating metastatic PCa progression.

Main Results:

  • AR signaling cascades are strongly implicated in the development of metastatic PCa.
  • Numerous downstream AR targets and cofactors influence AR pathway and metastatic phenotypes.
  • AR-driven metastatic signatures are linked to disease progression.

Conclusions:

  • AR signaling is a critical driver of prostate cancer metastasis.
  • Understanding AR-specific pathways is key to targeting metastatic PCa.
  • Further research into AR-driven metastatic signatures may reveal novel therapeutic strategies.